The Views of Indian Practitioners on Deprescribing
Deprescribing, “a structured approach to drug discontinuation”1 is rapidly becoming a trend worldwide. Though the Western world has accepted and adopted this approach towards prudent and rational therapy, the concept continues to be controversial in developing countries. The decision to deprescribe any medicine is complicated by the dearth of risk-benefit data and risk of therapeutic failure or withdrawal symptoms. But deprescribing has proven to be a legitimate solution to the age-old challenges of non-adherence, polypharmacy, risk of adverse drug reactions (ADRs), and use of potentially inappropriate medications (PIMs). As the responsibility of prescribing and monitoring of drug therapy falls primarily on physicians, understanding their views on deprescribing is of utmost importance. Hopefully the decision is made after weighing both the risks and benefits of deprescribing.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they do not have a conflict of interest.
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was taken from all involved participants. This article does not contain any studies with animals performed by any of the authors.